Library
Research peptide guides
Identity data, mechanism summaries, reconstitution protocols, and selected literature — for qualified laboratory research only.
BPC-157
Synthetic pentadecapeptide — NO/eNOS, VEGFR2, EGR-1 signalling in connective-tissue research.
Read guide →CJC-1295 (No DAC)
DPP-IV-resistant GHRH(1-29) analogue — pulse-mimicking GHRHR agonist, ~30 min half-life.
Read guide →Epithalon
Synthetic pineal tetrapeptide — telomerase / hTERT, melatonin rhythm, antioxidant research.
Read guide →GHK-Cu
Copper tripeptide — collagen/ECM, MMP/TIMP, VEGF, Nrf2/ARE, anti-NF-κB in fibroblast research.
Read guide →How to Read a Peptide COA
A lab-forward guide to interpreting HPLC purity, identity testing, batch numbers, and COA limitations.
Read guide →Ipamorelin
Selective GHSR-1a agonist — pituitary GH secretion without ACTH/cortisol/prolactin activation.
Read guide →MOTS-c
Mitochondria-derived peptide — AMPK activation via folate/AICAR, age-dependent decline, "exercise mimetic" research.
Read guide →NAD+
Redox coenzyme and sirtuin / PARP / CD38 substrate — central to ageing & metabolic research.
Read guide →Peptide Stability and Storage Guide
Storage variables that affect lyophilized and reconstituted research peptides.
Read guide →PT-141
CNS-selective MC3R / MC4R agonist — central arousal, MC4R–oxytocin, MC4R–dopamine research.
Read guide →Reconstitution Best Practices for Lyophilized Research Peptides
A conservative SOP framework for dissolving lyophilized RUO peptides without damaging the material.
Read guide →Retatrutide
GLP-1R + GIPR + GCGR tri-agonist — adds glucagon-receptor thermogenesis arm.
Read guide →Semaglutide
GLP-1 receptor mono-agonist — long-acting albumin-binding analogue for incretin research.
Read guide →Sermorelin
Native GHRH(1-29) — short-half-life reference GHRHR agonist for pituitary research.
Read guide →TB-500
Thymosin β4 analogue — G-actin sequestration, PINCH-ILK-Akt survival, HIF-1α hypoxia response.
Read guide →Tesamorelin
Full-length GHRH(1-44) with fatty-acid N-terminal modification — intermediate half-life (~25–38 min).
Read guide →Tirzepatide
Dual GLP-1R / GIPR agonist — partial GLP-1 / GIP-receptor pharmacology in metabolic and adipocyte research.
Read guide →